DiaMedica Announces Issuance of European Composition of Matter Patent and Additional Worldwide Filings for DM199
MINNEAPOLIS, MINNESOTA–(Marketwired – March 20, 2017) – DiaMedica Therapeutics Inc. (the “Company“) (TSX VENTURE:DMA)(OTCQB:DMCAF), today announced that the European [...]